| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26,155 |
17,883 |
$1.93M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,945 |
2,912 |
$381K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,113 |
1,724 |
$220K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,980 |
1,592 |
$213K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,797 |
1,516 |
$206K |
| 96127 |
|
9,436 |
6,678 |
$204K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,893 |
1,225 |
$175K |
| 99050 |
|
9,224 |
7,006 |
$123K |
| 99174 |
|
7,254 |
6,019 |
$115K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,647 |
4,443 |
$112K |
| 92587 |
|
3,547 |
2,736 |
$92K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,092 |
3,674 |
$82K |
| 96160 |
|
2,917 |
2,474 |
$53K |
| 92558 |
|
2,470 |
2,168 |
$51K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
488 |
387 |
$49K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,015 |
873 |
$46K |
| 96111 |
|
511 |
472 |
$39K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,044 |
933 |
$38K |
| 99188 |
|
1,780 |
1,408 |
$33K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,174 |
845 |
$20K |
| 99442 |
|
424 |
325 |
$16K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,458 |
1,257 |
$16K |
| D0145 |
Oral evaluation for a patient under three years of age |
239 |
219 |
$5K |
| D1206 |
Topical application of fluoride varnish |
240 |
219 |
$4K |
| 99401 |
|
109 |
102 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
177 |
165 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
267 |
238 |
$3K |
| 92650 |
|
74 |
69 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
60 |
44 |
$616.05 |
| 86580 |
|
18 |
14 |
$81.38 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
60 |
44 |
$64.71 |
| 90688 |
|
93 |
67 |
$0.54 |
| 90685 |
|
100 |
99 |
$0.11 |
| 90633 |
|
867 |
697 |
$0.10 |
| 90651 |
|
841 |
702 |
$0.08 |
| 90686 |
|
1,476 |
1,416 |
$0.07 |
| 90715 |
|
297 |
223 |
$0.06 |
| 90734 |
|
148 |
97 |
$0.04 |
| 90672 |
|
151 |
149 |
$0.03 |
| 90744 |
|
48 |
41 |
$0.01 |
| 90670 |
|
461 |
439 |
$0.00 |
| 90710 |
|
87 |
67 |
$0.00 |
| 90644 |
|
92 |
86 |
$0.00 |
| 90461 |
|
361 |
229 |
$0.00 |
| 90671 |
|
29 |
29 |
$0.00 |
| 90698 |
|
492 |
468 |
$0.00 |
| 90619 |
|
59 |
47 |
$0.00 |